Cancer gene therapy

Keyphrases

Publications

volume 31, number 7, 2024

Dong Zhang, Min Wang, Shiya Ma, Min Liu, Wenwen Yu, Xiying Zhang, Ting Liu, Shaochuan Liu, Xiubao Ren, Qian Sun
Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages. Cancer gene therapy 31 (7) (2024)
Lu Wang, Huijuan Liu, Qinglu Wu, Yiqian Liu, Zhenpeng Yan, Guohui Chen, Yao Shang, Songrui Xu, Qichao Zhou, Ting Yan, Xiaolong Cheng
miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39. Cancer gene therapy 31 (7) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Lu Wang, Huijuan Liu, Qinglu Wu, Yiqian Liu, Zhenpeng Yan, Guohui Chen, Yao Shang, Songrui Xu, Qichao Zhou, Ting Yan, Xiaolong Cheng
miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39. Cancer gene therapy 31 (7) (2024)
Ju Chen, Neha Singh, Xiaoyang Ye, Eileen Victoria Meehan, Kepeng Wang
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis. Cancer gene therapy 31 (7) (2024)
Yining Tang, Xi Pu, Xiao Yuan, Zhonghao Pang, Feng Li, Xu Wang
Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential. Cancer gene therapy 31 (7) (2024)
Jie Gao, Anying Xiong, Jiliu Liu, Xiaolan Li, Junyi Wang, Lei Zhang, Yao Liu, Ying Xiong, Guoping Li, Xiang He
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer gene therapy 31 (7) (2024)
Ju Chen, Neha Singh, Xiaoyang Ye, Eileen Victoria Meehan, Kepeng Wang
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis. Cancer gene therapy 31 (7) (2024)
Jie Gao, Anying Xiong, Jiliu Liu, Xiaolan Li, Junyi Wang, Lei Zhang, Yao Liu, Ying Xiong, Guoping Li, Xiang He
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer gene therapy 31 (7) (2024)
Yining Tang, Xi Pu, Xiao Yuan, Zhonghao Pang, Feng Li, Xu Wang
Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential. Cancer gene therapy 31 (7) (2024)
Giulia Pagani, Paolo Gandellini
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer. Cancer gene therapy 31 (7) (2024)
Dandan Zheng, Wenying Chen, Juanfei Peng, Xianxian Huang, Shineng Zhang, Yanyan Zhuang
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m 6 A-modified PTEN mRNA in pancreatic ductal adenocarcinoma. Cancer gene therapy 31 (7) (2024)
Jie Gao, Anying Xiong, Jiliu Liu, Xiaolan Li, Junyi Wang, Lei Zhang, Yao Liu, Ying Xiong, Guoping Li, Xiang He
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer gene therapy 31 (7) (2024)
Domenica Ronchetti, Valentina Traini, Ilaria Silvestris, Giuseppina Fabbiano, Francesco Passamonti, Niccolò Bolli, Elisa Taiana
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers. Cancer gene therapy 31 (7) (2024)
Joris Guyon, Sandy Haidar Ahmad, Ranim El Baba, Mégane Le Quang, Andreas Bikfalvi, Thomas Daubon, Georges Herbein
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes. Cancer gene therapy 31 (7) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Domenica Ronchetti, Valentina Traini, Ilaria Silvestris, Giuseppina Fabbiano, Francesco Passamonti, Niccolò Bolli, Elisa Taiana
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers. Cancer gene therapy 31 (7) (2024)
Ju Chen, Neha Singh, Xiaoyang Ye, Eileen Victoria Meehan, Kepeng Wang
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis. Cancer gene therapy 31 (7) (2024)
Domenica Ronchetti, Valentina Traini, Ilaria Silvestris, Giuseppina Fabbiano, Francesco Passamonti, Niccolò Bolli, Elisa Taiana
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers. Cancer gene therapy 31 (7) (2024)
Xiaoyu Ruan, Yundong Xiong, Xiaoman Li, Ence Yang, Jiadong Wang
Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy. Cancer gene therapy 31 (7) (2024)

volume 31, number 8, 2024

Rui Ma, Xinlin Xu
Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis. Cancer gene therapy 31 (8) (2024)
Jordan Quenneville, Albert Feghaly, Margaux Tual, Kiersten Thomas, François Major, Etienne Gagnon
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform. Cancer gene therapy 31 (8) (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer gene therapy 31 (8) (2024)
Eunbi Lee, Yoon Jung Park, Anders M Lindroth
H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. Cancer gene therapy 31 (8) (2024)
Han Zhang, Taotao Zheng, Chuan Qin, Xinyue Zhang, Han Lin, Xiaoping Huang, Qiang Liu, Shichuan Chang, Li Zhang, Jing Guo, Yao Zhang, Chunxiang Bian, Huawen Liu
CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status. Cancer gene therapy 31 (8) (2024)
Valentine De Castro, Jeanne Galaine, Romain Loyon, Yann Godet
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy. Cancer gene therapy 31 (8) (2024)
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer gene therapy 31 (8) (2024)
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer gene therapy 31 (8) (2024)
Changkun Liu, Zhuo Zou, Shengming Lu, Kun Jin, Ye Shen, Tianbao Huang, Weijian Li, Guangchen Zhou
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Changkun Liu, Zhuo Zou, Shengming Lu, Kun Jin, Ye Shen, Tianbao Huang, Weijian Li, Guangchen Zhou
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. Cancer gene therapy 31 (8) (2024)
Eunbi Lee, Yoon Jung Park, Anders M Lindroth
H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Jordan Quenneville, Albert Feghaly, Margaux Tual, Kiersten Thomas, François Major, Etienne Gagnon
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform. Cancer gene therapy 31 (8) (2024)
Xujun Li, Jing Jiang, Qian Wu, Tianzi You, Fan Yang
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells. Cancer gene therapy 31 (8) (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)
Fei Wang, Shuo Zhang, Fengjiao Sun, Weiwei Chen, Cuilan Liu, Hongliang Dong, Bingjie Cui, Lingyu Li, Chunlong Sun, Wen Du, Bin Liu, Wanfeng Fan, Jiong Deng, Clemens A Schmitt, Xiuwen Wang, Jing Du
Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model. Cancer gene therapy 31 (8) (2024)
Shiyong Xin, Yanwei Zhang, Zhenhua Zhang, Ziyao Li, Xianchao Sun, Xiang Liu, Liang Jin, Weiyi Li, Chaozhi Tang, Wangli Mei, Qiong Cao, Haojie Wang, Zhihao Wei, Zhen Zhou, Rongbing Li, Xiaofei Wen, Guosheng Yang, Weihua Chen, Junhua Zheng, Lin Ye
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma. Cancer gene therapy 31 (8) (2024)
Rui Shi, Rong Zhao, Yan Shen, Sitian Wei, Tangansu Zhang, Jun Zhang, Wan Shu, Shuangshuang Cheng, Hua Teng, Hongbo Wang
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer gene therapy 31 (8) (2024)
Letizia Rinella, Gloria Fiorentino, Mara Compagno, Cristina Grange, Massimo Cedrino, Francesca Marano, Ornella Bosco, Elena Vissio, Luisa Delsedime, Patrizia D'Amelio, Benedetta Bussolati, Emanuela Arvat, Maria Graziella Catalano
Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Eunbi Lee, Yoon Jung Park, Anders M Lindroth
H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. Cancer gene therapy 31 (8) (2024)
Eunbi Lee, Yoon Jung Park, Anders M Lindroth
H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. Cancer gene therapy 31 (8) (2024)
Jordan Quenneville, Albert Feghaly, Margaux Tual, Kiersten Thomas, François Major, Etienne Gagnon
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform. Cancer gene therapy 31 (8) (2024)
Shiyong Xin, Yanwei Zhang, Zhenhua Zhang, Ziyao Li, Xianchao Sun, Xiang Liu, Liang Jin, Weiyi Li, Chaozhi Tang, Wangli Mei, Qiong Cao, Haojie Wang, Zhihao Wei, Zhen Zhou, Rongbing Li, Xiaofei Wen, Guosheng Yang, Weihua Chen, Junhua Zheng, Lin Ye
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma. Cancer gene therapy 31 (8) (2024)
Han Zhang, Taotao Zheng, Chuan Qin, Xinyue Zhang, Han Lin, Xiaoping Huang, Qiang Liu, Shichuan Chang, Li Zhang, Jing Guo, Yao Zhang, Chunxiang Bian, Huawen Liu
CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status. Cancer gene therapy 31 (8) (2024)
Xujun Li, Jing Jiang, Qian Wu, Tianzi You, Fan Yang
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells. Cancer gene therapy 31 (8) (2024)
Jordan Quenneville, Albert Feghaly, Margaux Tual, Kiersten Thomas, François Major, Etienne Gagnon
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform. Cancer gene therapy 31 (8) (2024)